This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
This article is within the scope of WikiProject Autism, a collaborative effort to improve the coverage of all aspects of autism and autistic culture on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.AutismWikipedia:WikiProject AutismTemplate:WikiProject AutismAutism articles
Selegiline is within the scope of WikiProject Disability. For more information, visit the project page, where you can join the project and/or contribute to the discussion.DisabilityWikipedia:WikiProject DisabilityTemplate:WikiProject DisabilityDisability articles
The contents of the Emsam page were merged into Selegiline. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page.
Orally Disintegrating Tabet for Selegiline (Zelapar) approved by FDA
Zelapar, produced by Valeant Pharmaceuticals International, was approved by the FDA in June 2006 for the treatment of Parkinson's Disease.
